Dr. Anil Mandhani
Experience: Over 35 years
Fortis Memorial Research Institute (FMRI)
Gurugram, India
Introduction
Dr. Anil Mandhani is the Executive Director and Chairman of Urology and Kidney Transplant at FMRI. He actually holds a massive clinical footprint, having successfully executed over 1,500 kidney transplants and well over 550 advanced robotic cancer surgeries.
About Dr. Anil Mandhani
With over thirty-five years of surgical experience, Dr. Anil Mandhani basically handles the most complicated urological cases out there. He did his MCh in Urology at SGPGIMS Lucknow, where he eventually became a senior academic professor and personally trained over 100 urology residents. Then took his skills to the US, picking up a highly prestigious clinical fellowship in robotic uro-oncology right at the Brady Urology Center at Weill Cornell in New York.
He is heavily focused on robotic cancer surgery. Beyond oncology, he is a major force in renal transplants. Takes on the really tough, high-risk cases like ABO-incompatible (blood group mismatch) surgeries and complex revision transplants when earlier surgeries didn’t hold up. He doesn’t just use surgical tools; he actually invents them. Holds a patent and won an Innovation Award for designing a novel endopyelotomy device. Before taking the lead at Fortis, he was the Chairman of Urology at Medanta.
Qualifications
- MBBS — Pandit JNM Medical College, Raipur.
- MS (General Surgery) — Pandit JNM Medical College, Raipur.
- MCh (Urology) — SGPGIMS, Lucknow.
- DNB (Urology) — National Board of Examinations, New Delhi.
Awards & Recognition
- Innovation Award from the Urological Society of India for designing a surgical device.
- International Guest Scholarship by the American College of Surgeons.
- Recognized as Best Reviewer by the globally acclaimed Journal of Urology.
- Previously Chairman of Urology at Medanta and Professor at SGPGIMS.
- Member of AUA, EAU, and BAUS.
Specialities & Expertise
- Robotic nerve-sparing radical prostatectomy.
- Robotic partial nephrectomy for kidney cancer.
- Robotic radical cystectomy with neobladder reconstruction.
- Kidney transplant, including ABO-incompatible and revision cases.
- Complex uro-oncological surgery.
- Endopyelotomy and reconstructive urology.
Patient Experience & Approach
Prostate cancer patients say Dr. Anil Mandhani explains the robotic nerve-sparing approach honestly. Kidney cancer families where partial nephrectomy was possible mentioned that he saved the healthy kidney tissue instead of defaulting to full removal, which meant no dialysis and normal kidney function afterward. His Brady fellowship training shows in how precisely robotic cases get planned and how carefully cancer margins get assessed before and during surgery.